Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

NCT04938232

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations
  • University of Chicago Medicine Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723

Conditions
Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, not recruiting

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

NCT03407144

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Children's Hospital of Alabama ( Site 0023) Birmingham, Alabama, United States
  • Phoenix Childrens Hospital ( Site 0034) Phoenix, Arizona, United States
  • Arkansas Children's Hospital ( Site 0046) Little Rock, Arkansas, United States
  • Kaiser - Orange County ( Site 0084) Anaheim, California, United States
View all 93 locations
View Trial Details

Related conditions